These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2490272)

  • 21. [80 years' of internal medicine education at the medical school of the university in Belgrade (1922-2002)].
    Micić J; Micić D
    Srp Arh Celok Lek; 2003; 131(7-8):351-64. PubMed ID: 14692153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compound scale-up at the discovery-development interface.
    Nikitenko AA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The control of vascular smooth muscle function: my life-long learning and continuous discovery with Professor E.E. Daniel.
    Kwan CY
    Can J Physiol Pharmacol; 2005; 83(8-9):669-74. PubMed ID: 16333369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
    Whitebread S; Hamon J; Bojanic D; Urban L
    Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for dealing with reactive intermediates in drug discovery and development.
    Nassar AE; Lopez-Anaya A
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):126-36. PubMed ID: 14982156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical appraisal of structure-based drug design.
    Tintelnot-Blomley M; Lewis RA
    IDrugs; 2006 Feb; 9(2):114-8. PubMed ID: 16523401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.
    Arneric SP; Holladay M; Williams M
    Biochem Pharmacol; 2007 Oct; 74(8):1092-101. PubMed ID: 17662959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New horizons in drug metabolism, pharmacokinetics and drug discovery.
    Palmer AM
    Drug News Perspect; 2003; 16(1):57-62. PubMed ID: 12682673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macromolecular crystallography as a tool for investigating drug, enzyme and receptor interactions.
    Oakley AJ; Wilce MC
    Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):145-51. PubMed ID: 10744339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide therapeutics: current status and future directions.
    Fosgerau K; Hoffmann T
    Drug Discov Today; 2015 Jan; 20(1):122-8. PubMed ID: 25450771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction.
    Science; 1948 Aug; 108(2798):155. PubMed ID: 17770994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The slope parameter and the receptor reserve.
    Giraldo J
    Trends Pharmacol Sci; 1998 Nov; 19(11):445; Discussion 445-6. PubMed ID: 9850607
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular similarity. 2. The structural basis of drug design].
    Kubinyi H
    Pharm Unserer Zeit; 1998 Jul; 27(4):158-72. PubMed ID: 9718968
    [No Abstract]   [Full Text] [Related]  

  • 39. Higher plants--the sleeping giant of drug development.
    Farnsworth NR; Morris RW
    Am J Pharm Sci Support Public Health; 1976; 148(2):46-52. PubMed ID: 984178
    [No Abstract]   [Full Text] [Related]  

  • 40. RCN R&D.
    Nurs Manag (Harrow); 2004 Jun; 11(3):37. PubMed ID: 27724289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.